SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 4 filers reported holding SILVER STD RES INC in Q1 2012. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $410,000 | +96.2% | 42,200 | +114.1% | 0.00% | – |
| Q1 2017 | $209,000 | +4.5% | 19,707 | +4.4% | 0.00% | -100.0% |
| Q1 2013 | $200,000 | -24.8% | 18,881 | +5.6% | 0.00% | 0.0% |
| Q4 2012 | $266,000 | +6.8% | 17,880 | +15.1% | 0.00% | 0.0% |
| Q3 2012 | $249,000 | +50.9% | 15,535 | +41.2% | 0.00% | 0.0% |
| Q1 2012 | $165,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |